Mor­ton Grove Phar­ma­ceu­ti­cals to dis­con­tin­ue op­er­a­tions at Illi­nois site due to on­go­ing man­u­fac­tur­ing is­sues

An In­di­an man­u­fac­tur­er is shut­ter­ing its Illi­nois site due to man­u­fac­tur­ing is­sues that have built up over sev­er­al years.

Mor­ton Grove Phar­ma­ceu­ti­cals, a gener­ics man­u­fac­tur­er and sub­sidiary of Mum­bai-based drug com­pa­ny Wock­hardt, has agreed to dis­con­tin­ue all man­u­fac­tur­ing, pro­cess­ing and drug dis­tri­b­u­tion from its Illi­nois site af­ter the De­part­ment of Jus­tice ac­cused it of sell­ing adul­ter­at­ed drugs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER